Vubotics Stock Net Income
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess Vubotics' long-term financial health and intrinsic value.
Vubotics |
Vubotics Company Net Income Analysis
Vubotics' Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Vubotics Net Income | (2.65 M) |
Most of Vubotics' fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Vubotics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, Vubotics reported net income of (2.65 Million). This is much lower than that of the Software sector and significantly lower than that of the Information Technology industry. The net income for all United States stocks is notably higher than that of the company.
Vubotics Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Vubotics' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Vubotics could also be used in its relative valuation, which is a method of valuing Vubotics by comparing valuation metrics of similar companies.Vubotics is currently under evaluation in net income category among its peers.
Vubotics Fundamentals
| Return On Asset | -1.8 | |||
| Current Valuation | 306.09 K | |||
| Price To Earning | (0.02) X | |||
| Price To Sales | 24,940 X | |||
| Revenue | 37 K | |||
| Gross Profit | 25.27 K | |||
| EBITDA | (2.59 M) | |||
| Net Income | (2.65 M) | |||
| Cash And Equivalents | 592.21 K | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 400 K | |||
| Current Ratio | 0.36 X | |||
| Book Value Per Share | (0.05) X | |||
| Cash Flow From Operations | (1.61 M) | |||
| Beta | 8.61 | |||
| Market Capitalization | 630.29 M | |||
| Total Asset | 544.06 K | |||
| Working Capital | (2.74 M) | |||
| Current Asset | 593 K | |||
| Current Liabilities | 3.34 M | |||
| Net Asset | 544.06 K |
About Vubotics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Vubotics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vubotics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vubotics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Consideration for investing in Vubotics Stock
If you are still planning to invest in Vubotics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Vubotics' history and understand the potential risks before investing.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |